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Glucocorticoid receptor antagonizes EGFR function
to regulate eyelid development
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ABSTRACT  The glucocorticoid receptor (GR) plays a crucial role in epidermal morphogenesis
during embryonic development, as demonstrated by analyzing genetically modified mouse
models of GR gain- and loss-of-function. Eyelid formation constitutes a useful model to study
epithelial development, as it requires coordinated regulation of keratinocyte proliferation, apop-
tosis and migration. We have analyzed this biological process in GR-/- embryos during ontogeny.
Our data demonstrate that GR deficiency results in delayed and impaired eyelid closure, as
illustrated by increased keratinocyte proliferation and apoptosis along with impaired differentia-
tion in GR-/- eyelid epithelial cells. These defects are due, at least in part, to the lack of antagonism
between GR and epidermal growth factor receptor (EGFR) signaling, causing sustained activation
of the MAPK/AP-1 pathway and the upregulation of keratin K6 at embryonic stage E18.5.
Additionally, we demonstrate that GR regulates epithelial cell migration in vitro by interfering
with EGFR-mediated signaling. Overall, GR/EGFR antagonism appears as a major mechanism
regulating ocular epithelial development.
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Introduction
It is known that the glucocorticoid receptor (GR) plays a crucial
role during embryogenesis, since this ligand-activated transcrip-
tion factor is required for maturation of vital organs such as the
lung, heart, kidney, gut and epidermis (reviewed in Wintermantel
et al., 2004; Revollo and Cidlowski, 2009). GR exerts its biological
effects through two different mechanisms that involve DNA bind-
ing-dependent and -independent actions, which can be geneti-
cally separated and are commonly refered to as transactivation
and transrepression functions. In fact, knock-out GR-/- mice die
perinatally whereas mice carrying a point mutation which abro-
gates the dimerization- dependent DNA binding of GR (GRdim/dim)
are viable (Cole et al., 1995; Reichardt et al., 1998). This distinc-
tion, however, is not so clear-cut since GR monomers are also
able to bind certain gene promoters and thus, regulate gene
transcription (Adams et al., 2003; Rogatsky et al., 2003): In the
last years, we have demonstrated that GR is a key player in
epithelial development by analyzing genetically modified mouse
models of GR gain- and loss-of-function (Pérez et al., 2001;
Cascallana et al., 2003; Cascallana et al., 2005; Donet et al.,
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2008; Bayo et al., 2008). We have recently reported that only the
epidermis of GR-/- but not GRdim/dim embryos shows major defects,
suggesting that dimerization dependent DNA binding by GR is
dispensible for epidermal development (Bayo et al., 2008). In
addition, we have shown that transgenic mice with keratinocyte-
targeted overexpression of GR (K5-GR mice) featured numerous
epithelial defects including epidermal defects and an eyelid open-
ing at birth phenotype (EOB). Overexpression of GR
transrepression function in keratinocytes (K5-GR-TR mice) also
elicited epithelial alterations that partially overlapped with those
found in K5-GR mice (Cascallana et al., 2005; Donet et al., 2008).
Remarkably, K5-GR-TR mice featured an EOB phenotype iden-
tical to K5-GR mice, indicating that the transrepression function of
the GR is sufficient to cause these epithelial ocular anomalies
(Donet et al., 2008).
Eyelid formation represents a useful model to study epithelial
development since this biological process requires spatio-tempo-
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ral coordination of cellular proliferation, migration, differentiation
and apoptosis. In the mouse embryo, eyelid formation starts at
midgestation, when small invaginations of the surface ectoderm
begin to grow (E12.5), become distinguishable as protruding
edges (E14.5-E15.5) and gradually cover the corneal surface
until they fuse at E16.5. At E18.5, eyelids are unequivocally
closed and start to separate postnatally (P3-P5) until they reopen
around P12 (Kaufman and Bard, 1999). In this work, we analyzed
the consequences of GR functional inactivation in ocular develop-
ment by using GR-/- mice.’Our data show that GR is required to
modulate eyelid epithelial morphogenesis through regulation of
keratinocyte proliferation, apoptosis, differentiation and migra-
tion. It is known that GR suppresses keratin expression of either
mitotically-active basal keratinocytes (K5 and K14) or migration-
associated keratins K6 and K16. The mechanisms involve binding
of GR to AP-1 and interaction of four GR monomers with k6
promoter, respectively (Radoja et al., 2000; De Bosscher and
Haegeman, 2009). Accordingly, K5 and K6 expression was al-
tered in GR-/- epithelia. These actions were mediated, at least in
part, through interference with EGFR signaling, the loss of which
results in increased EGFR and MAPK/AP-1 activation and sus-
tained expression of the keratin K6. In vitro wound healing assays
demonstrated that constitutive GR overexpression in keratinocytes
drastically impairs cell migration and interferes with EGFR func-
tion suggesting that lack of cross-talk between GR and EGFR
pathway is one of the mechanisms causing delayed eyelid closure
in GR-/- embryos.
Results
We have anayzed eyelid closure in GR-/- embryos as in vivo
model to address the impact of GR loss-of-function in epithelial
morphogenesis. Macroscopically, GR-/- embryos showed open
eyelids at embryonic days E16.5 and E18.5. A detailed histo-
pathological analysis of wt and GR-/- littermates at distinct
timepoints showed severe anomalies in the eyelid formation of
GR-deficient mice throughout development (Fig. 1A, compare a-
d and a´-d´). In a wt developing mouse, eyelid closure is normally
completed in 24h, coinciding with the E15.5-E16.5 transition (Fig.
1A; a, b-d; asterisks indicate fused eyelids in GR+/+). In contrast,
Fig. 1. Delayed and impaired eyelid closure in glucocorticoid receptor (GR) null mice. (A) Histopatholgical analysis of wt and GR-/- embryos at
distinct developmental timepoints. Eyelid closure is normally completed at E15.5-E16.5 transition in wt embryos and eyelids remain fused until
postnatal age (a-d). In contrast, GR-/- embryos exhibited unfused eyelids at E16.5 and E18.5 (a´-c´, arrows) along with an abnormal corneal stroma with
increased cellularity (b´,c´, arrowheads). GR-/- newborn mice showed closed eyelids with abnormal epithelia and atypical corneal stroma (d´, asterisk
and arrowhead, respectively). Bar: 200 m. (B) Abnormal morphogenesis of eyelid epithelial cells in GR-/- early (E15.5) and late (E18.5) embryos.
Immunostaining for K5, K6, p63, K10 and loricrin was performed using specific antibodies. Note that both K5 and p63 expression stained two-to three
suprabasal layers of eyelid epithelia in GR-/- embryos as compared to more restricted labeling at the fused eyelids of GR+/+ individuals (K5 and p63;
see inset). Increased K6 expression at the eyelids tips of E15.5 (asterisks) was observed in wt mice. Elevated levels of K6 were detected in the unfused
GR-/- eyelids at E18.5, as compared with restricted K6 expression at closed eyelids of GR+/+ mice. Abnormal K10 and loricrin staining was apparent
in GR-/- eyelid epidermis relative to GR+/+ mice (K10 and loricrin; see inset). Bar: 100 m.
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GR-/- embryos revealed unfused eyelids at E16.5 and even at
E18.5 (Fig. 1A; b´, c´, arrows) along with an abnormal corneal
stroma with increased cellularity (Fig. 1A; b´, c´, arrowheads).
The eyelids of GR-/- newborn mice were closed but the epithelia
appeared abnormally enlarged and undifferentiated (Fig. 1A;
compare d and d´) and an atypical corneal stroma persisted.
Penetrance of the reported ocular phenotype in GR-/- mice was
89% (n=43), with either one or two eyes affected (54.55% and
45.45%, respectively).
As an attempt to understand how loss of GR is causing these
defects, we analyzed the expression of markers of keratinocyte
proliferation, migration and differentiation in the eyelid epithelia of
early (E15.5) and late (E18.5) embryos by immunostaining (Fig.
1B). In wt embryos, K5 expression was apparent in all epithelia
basal cells of the eyelids, cornea and conjunctiva (Fig. 1B, K5). In
GR-/- littermates, labeling of these epithelial cell layers was
similar, although additional K5 expression was detected
suprabasally in the eyelid epithelia (Fig. 1B, K5, see inset). The
epithelial-specific marker p63 was detected in keratinocytes of
GR+/+ and GR-/- embryo eyelids and cornea. However, p63
immunostaining at the leading edge of early and late GR-/- embryo
eyelids was more suprabasal as compared to the more restricted
p63 labeling at wt eyelid tips (Fig. 1B, p63).
In E15.5 wt mice, K6 was strongly expressed at the eyelids tips,
defining the migrating cells at the leading edge of this epithelium
(Fig. 1B, K6, asterisk). The conjuctival epithelium was also K6-
positive (not shown). Notably, at E18.5, where cell migration is no
longer required since eyelids are already fused, K6 immunostaining
was restricted to the closed eyelids (Fig. 1B). In contrast, GR-/-
embryos stained weakly for K6 at the eyelid borders at E15.5
whereas an abnormally strong K6 signal was detected at E18.5,
both at the tip of unfused GR-/- eyelids and in conjuctival epithe-
lium (Fig. 1B, K6, asterisk and data not shown). The observed K6
expression pattern indicates a delay in the ocular epithelia devel-
opment of GR-/- mice.
Previous reports described that eyelid fusion precedes epithe-
lial differentiation, since positive K10 staining was detected in
epithelial cells of wt embryos only after eyelid closure (Zhang et
al., 2005). We examined K10 and loricrin expression and found
that in E15.5 wt embryos, both markers were present in suprabasal
eyelid epithelia although absent at the leading edge. In E18.5 wt
embryos, only suprabasal cells of the fused eyelids stained
positive for both markers. In contrast, reduced staining of K10 and
loricrin was apparent in GR-/- eyelid epidermis of early embryos
whereas abnormal expression of these proteins persisted in the
unfused eyelids from GR-/- E18.5 embryos (Fig. 1B, K10 and
loricrin).
We further assessed altered proliferation in GR-/- eyelid epithe-
lial cells by measuring in vivo BrdU incorporation in GR-/- vs wt
E15.5 embryos, and found qualitative and quantitative differ-
ences among them (Fig. 2A, B). In wt embryos, most BrdU-
positive keratinocytes were detected in the basal cell of the eyelid
epithelia (black arrows). In contrast, augmented keratinocyte
proliferation was detected in basal (black arrows) and suprabasal
(red arrows) cells of GR-/- eyelids. When comparing the prolifera-
tion of eyelid basal cells, differences were found statistically
significant (Fig. 2A, 38.1% vs 28%, respectively, p<0.05). At later
developmental stages (E18.5), we could not detect increased
proliferation of the eyelid basal keratinocytes of GR-/- relative to wt
(data not shown). However, we found BrdU-positive nuclei in the
suprabasal layers of E18.5GR-/- eyelids, as occurred in E15.5 GR-
deficient embryos. Additionally, we detected augmented apopto-
sis in all eyelid epithelial layers of GR-deficient embryos by
TUNEL staining, in contrast with scarce apoptotic cells in wt
littermates (Fig. 2B, arrows). Overall, our results demonstrate that
GR is required for proper proliferation, apoptosis, migration and
differentiation of the eyelid epithelial cells of GR-/- embryos.
To further characterize the alterations in GR-/- eyelid closure,
we quantitated several parameters to estimate the percentage of
formation of the eyelid, leading edge and root, following the
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bryos. Note that augmented keratinocyte prolif-
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eter b the distance between the axis delimitat-
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center of the cornea. The Student t test was used to calculate statistical significance (n= 5, each
genotype) and differences considered to be statistically significant when p<0.05. Bar: 100 m.
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methodology described by Mine and co-workers (Mine et al.,
2005). For these measurements, we performed K6 immunostaining
to compare eyelid closure in GR-/- and wt E15.5 littermates, using
K6-positive cells to define the migrating epithelial cells (Fig. 2C).
In wt embryos, extension of both leading edge and the root was
already evident at E15.5 with estimated percentage of formation
of 14.5% and 45%, respectively (Fig. 2C). In sharp contrast, the
leading edge of GR null mice was not formed at this stage and it
was not apparent until E18.5 (Fig. 1B and data not shown). In
addition, root formation was reduced almost two-fold, as com-
pared to wt embryos. These determinations allowed us to quan-
titate the overall completion in GR-/- eyelid formation at E15.5 as
of 28% relative to 60% in wt (Fig. 2C).
It is well known that the epidermal growth factor (EGF) and its
receptor (EGFR) play a crucial role in epithelial development
(Zenz et al., 2003; Xia and Karin, 2004). The antagonism between
GR and EGFR signaling has been demonstrated in different
pathophysiological processes. However, this cross-talk has not
been examined in eyelid formation. In wt embryos, EGFR was
detected at the tip of eyelid epithelial cells around E15.5 but
decreased at E18.5, when eyelid closure had completed. In
contrast, EGFR protein expression was evident at E15.5 in GR-/
- embryos and remained abnormally high at E18.5, as compared
to wt (Fig. 3A, EGFR). The observed elevation in total EGFR
levels correlated with increased phosphorylated (p-)EGFR
immunostaining in GR-/- open eyelids at E18.5 (Fig. 3A, p-EGFR).
To ascertain whether GR could also regulate EGFR at the
transcriptional level, we examined the skin of E18.5 GR-/- em-
bryos as compared to wt littermates by quantitative RT-PCR (Fig.
3B). Our data demonstrated increased egfr mRNA levels in GR-
/- embryos, thus indicating additional mechanisms of GR/EGFR
biological antagonism.
We next examined whether increased EGFR signaling would
cause augmented ERK phosphorylation in the developing eyelids
of GR-/-embryos (Fig. 3C, p-ERK). Despite unchanged total ERK
levels in wt and GR-/-embryos (not shown), we detected p-ERK at
E15.5 only in GR-deficient eyelids. In E18.5 wt embryos, p-ERK
was restricted to the granular layer of closed eyelids whereas high
levels were still detected at the eyelid tip of GR-/- embryos. Overall,
our results suggest that proper (and transient) regulation of EGFR
signaling and its downstream effectors, such as ERK and K6, are
required during ocular epithelia development. Abnormally consti-
tutive activation and/or expression of these proteins, as in GR-
deficient embryos, likely results in impaired eyelid closure.
The formation of the mouse eyelid during the embryogenesis
is similar to the wound healing process since it requires coordi-
nated proliferation, migration and differentiation of keratinocytes
(reviewed in Martin and Parkhurst, 2004). We thus examined the
role of GR and its interference with EGFR function in epithelial cell
migration by in vitro wound healing assays using primary culture
keratinocytes (MPKs). Since cell confluence is necessary for
these experiments, and given that GR-/- MPKs exhibit abnormal
cell growth and apoptosis (Bayo et al., 2008), we evaluated MPKs
isolated from K5-GR transgenic mice, in which GR is constitu-
tively active (Pérez et al., 2001). This system allows us to evaluate
the role of GR in keratinocyte migration without adding exogenous
ligands, which can elicit different actions depending on dosing
and kinetics. Fig. 4 summarizes three independent wound scratch
Fig. 3. Glucocorticoid receptor (GR) interferes with EGFR-mediated signaling during eyelid development. (A) Immunofluorescences were
performed in GR-/- and GR+/+ embryos at E15.5 and E18.5 with specific antibodies against total EGFR and phosphorylated EGFR (p-EGFR). EGFR
expression was slightly induced in GR-/- relative to GR+/+ E18.5 embryos. Moreover, increased p-EGFR immunostaining was also detected in GR-/- E15.5
and E18.5 eyes. (B) Transcript levels of egfr were examined in skin of GR-/- and GR+/+ E18.5 embryos by quantitative RT-PCR. Asterisk denote that
differences in four individuals of each genotype were statistically significant; (student´s t test, p<0.05). (C) Immunostaining in GR-/- and GR+/+ embryos
at E15.5 and E18.5 for phosphorylated (p)-ERK. p-ERK was detected at E15.5 only in GR-deficient eyelids and the phosphorylation was sustained until
E18.5, in contrast to wt embryos, where p-ERK was restricted to the granular layer of closed eyelids. Bar: 100 m.
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experiments that elicited consistent results. In wt cells, keratinocyte
migration was 47.3% at 8h after scratching (t8) and was com-
pleted at 24h. In contrast, K5-GR MPKs exhibited 33.5% migra-
tion at t8, a marked delay that was still very prononunced at t24
(44.2%). For comparative purposes, we evaluated the response
of wt MPKs to the GC-analogue Dex and EGF (Fig. 4). As
previously described (Lee et al., 2005), Dex delayed and EGF
accelerated wt keratinocyte migration at t8 (35.2% and 100%,
respectively). At t24, retarded migration elicited by Dex treatment
was approximately 83.6%. Note that constitutive GR overexpres-
sion in K5-GR MPKs elicited effects similar to Dex treatment in wt
cells. The retarded migration of K5-GR MPKs was only slightly
potentiated by Dex treatment (data not shown). K5-GR
keratinocytes also responded to EGF although with delayed
kinetics as compared to wt cells (64.7% and 97.3% at t8 and t24,
respectively).
Discussion
During mammalian embryogenesis, the surface ectoderm gives
rise to the corneal and conjunctival epithelia and the epidermis of
the eyelid. Eyelid formation takes place during mouse embryonic
days E15.5 to E16.5 and requires the proliferation and migration
of epithelial cells to cover the ocular surface, acting as a protective
barrier for normal eye development (Xia and Karin, 2004). This
process is similar to epidermal formation which results in the
acquisition of a competent barrier necessary to protect the organ-
ism from environmental damage (Segre, 2006). Our recent work
has shown that GR is required for epidermal formation since its
absence results in an immature epidermal barrier (Bayo et al.,
2008). Analogously, histological evaluation of GR-/- embryos
showed delayed and impaired eyelid closure, which took around
72-96h to complete instead of 24h, as occurs in wt mice (Fig. 1).
Delayed progression in total eyelid formation was around 50% in
GR-/- E15.5 embryos and approximately 78.3% in E18.5 individu-
als relative to their wt counterparts (Fig. 2 and data not shown).
The fact that GR modulates proliferation and apoptosis of eyelid
epithelial cells (Fig. 2 A,B) adds to our previous findings in
epidermis showing that this nuclear receptor regulates these
processes in a cell-autonomous manner (Bayo et al., 2008) and
highlights a general role of GR in epithelial morphogenesis. Our
data also illustrate that these processes need to be temporally
coordinated in order to complete proper eyelid formation. We
found increased expression of markers of keratinocyte prolifera-
tion (K5, p63) in the eyelid epithelial cells of GR-/- embryos relative
to wt, at a time where these markers should be restricted to the
basal cell layer and a few suprabasal cells at the site of fusion (Fig.
1). We also observed incomplete differentiation of epithelial cells
in GR-/- embryos (Fig. 1, K10 and loricrin), most likely due to the
absence of eyelid fusion, which should precede terminal differen-
tiation (Zhang et al., 2005).
Our previous studies reported an EOB phenotype in K5-GR
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Fig. 4. Glucocorticoid receptor (GR) delays keratinocyte migration in in vitro wound scratch assays. Wound scratch experiments were
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estimated as indicated in Materials and Methods. Bar: 100 m.
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and K5-GR-TR embryos that was indeed the most consistent
epithelial defect found in both transgenic mouse models
(Cascallana et al., 2003; Donet et al., 2008). In addition, our data
demonstrated that the transrepression function of the GR is
sufficient to cause these epithelial anomalies (Donet et al., 2008).
It was indeed surprising to find open eyelids in GR gain- and loss-
of-function mouse models although, undoubtedly, it further sup-
ports a key role for this transcription factor in ocular epithelial
morphogenesis. Since GR-/- embryos exhibit increased corticos-
terone levels due to a feedback mechanism mediated by the
hypothalamus-pituitary-adrenal axis (Cole et al., 1995 and our
unpublished data), it is possible that elevated hormone levels may
be acting through the mineralocorticoid receptor (MR) in GR-/-
ocular epithelial cells and thus mimick increased GC-signaling,
even in the absence of GR. Supporting this hypothesis, mice
overexpressing the MR in keratinocytes (K5-MR) showed an EOB
phenotype virtually identical to that of K5-GR and K5-GR-TR
embryos (Sainte Marie et al., 2007). The similarities between K5-
GR and K5-MR mouse models extend to epidermal defects,
including abnormal hair follicle formation and hypoplastic epider-
mis (Sainte Marie et al., 2007). GR and MR recognize the same
hexameric DNA response elements and, theoretically, could
transactivate the same gene promoters (Kumar and Litwack,
2009). A subset of epithelial-specific genes may be regulated in
common by both nuclear receptors. In this regard, our data show
that GR represses egfr transcription in skin (Fig. 3B). However,
MR has been reported to upregulate egfr mRNA expression in
other cell types (Grossman et al., 2007).
GR exerts many of its biological actions through interactions
with distinct signaling pathways, including MAPK/AP-1 and NF-
kappaB (reviewed in De Bosscher and Haegeman, 2009). Two
main pathways have been involved in eyelid formation, the
MEKK1/JNK/c-Jun pathway which transductes TGF- and activin
signals and the TGF-/EGFR/ERK pathway; both result in AP-1
activation (revised in Xia and Karin, 2004). EGFR plays a key role
in eye morphogenesis and, accordingly, disruption of the EGFR
locus resulted in an EOB phenotype as well as immature devel-
opment of skin epithelial cells, teeth, lung and gastrointestinal
tract (reviewed in Sibilia et al., 2007). We analyzed whether EGFR
was abnormally expressed and/or activated in GR-/- embryos, and
also investigated alterations in its downstream effector ERK. The
expression pattern of both phosphorylated EGFR and ERK dem-
onstrated sustained activation in GR-/- E18.5 embryos, a timepoint
at which these proteins should be normally restricted to the more
differentiated epithelial cells at the fused eyelids (Fig. 3). Sus-
tained expression of ERK and K6 in the eyelids of GR-/- E18.5
mice is consistent with previous reports in vitro showing that EGF-
signaling can induce the expression of K6 through AP-1 sites in
its promoter (Lee et al., 2005).
The process of eyelid closure parallels skin wound healing,
which also requires proliferation and migration to complete re-
epithelization across the wound (reviewed in Martin and Parkhurst,
2004; Barrientos et al., 2008). The expression of the migration-
associated keratin K6 increases during wound healing in adult
skin and is required for normal re-epithelialization (Wong and
Coulombe, 2003; Wojcik et al., 2000). Activated GR can inhibit the
expression of specific keratins through several mechanisms
involving transcriptional and non-transcriptional events (Radoja
et al., 2000). GCs were shown to cause cytoskeleton remodeling
by repressing K6/K16 expression and thus, inhibiting keratinocyte
migration and causing deregulated growth and differentiation
(Stojadinovic et al., 2005). These GR actions are relevant during
the wound healing process, whereby K6 expression in suprabasal
keratinocytes at the wound´s edge is repressed once the epider-
mis covers the wound. This occurs through antagonism between
GR and EGFR and involves activation of -catenin and c-myc and
blockade of EGF effects through the formation of a complex
consisting in four GR monomers, -catenin and coactivator-
associated-arginine-methyltransferase-1 (Lee et al., 2005;
Stojadinovic et al., 2005).
So far, the in vivo cross-talk between GR/EGFR in eyelid
formation had not been previously investigated. Our data in vivo
show that GR is a master regulator required for the spatio-
temporal control of the EGFR/MAPK/AP-1 signaling at the lead-
ing edge of eyelid keratinocytes and suggest that this interference
is required for normal eyelid development.
Materials and Methods
Animals
All mice were handled in accordance with the current Spanish and
European normative which governs research with animals (Real Decreto
1201/2005, B.O.E. #252, 10 of October, 2005 and Convenio Europeo 1-
2-3 del 18/3/1986).
GR-/- and K5-GR mice have been previously reported (Cole et al.,
1995; Pérez et al., 2001). GR+/- hemizygous mice (B6D2/F1) intercrosses
were programmed to obtain GR-/-, GR+/- and GR+/+ mice. Embryos were
obtained by cesarean derivation at the indicated day post-conception
(dpc; the morning of the day that the vaginal plug was seen was
considered as day 0.5 pc.). For histopathological evaluation, we analyzed
embryos of different timepoints from GR-/-, GR+/- and GR+/+ genotypes
(n=43). For preparation of mouse primary keratinocytes (MPKs) and
wound scratch assays, skin from K5-GR mice and wt newborn littermates
was excised and processed (n=38).
Antibodies
The antibodies used included rabbit polyclonal antibodies against
keratin K5 (PRB-160P), K6 (PRB-169P), K10 (PRB-159P) and loricrin
(PRB-145P) from Covance (Babco, Berkeley, CA). Antibodies against
p63 (sc-404), p-c-jun (sc-822) and EGFR (sc-03) were from Santa Cruz
Biotechnology, Inc., (Santa Cruz, CA) and anti-p-EGFR (53A5), anti-p-
ERK (Thr202/Tyr204) (#4376) and p-JNK (Thr183/Tyr185) (# 9251) were
purchased from Cell Signaling (Cell Signaling Technology Inc., Beverley,
MA). Secondary biotin-conjugated anti-rabbit or anti-mouse antibodies
were from Jackson ImmunoResearch (Jackson ImmunoResearch Labo-
ratories, Inc. West Grove, PA).
Histological and Immunohistochemical analysis
Embryo heads were fixed in 4% paraformaldehyde (PFA) or 70%
ethanol and embedded in paraffin. Consecutive 3 to 4 m-thick sections
were obtained. For histopathology, sections were stained with hematoxy-
lin/eosin. Prior to immunostaining, paraffin sections were dewaxed and
microwaved in 10 mM citrate solution. For immunohistochemistry, paraf-
fin sections were blocked with 5% fetal bovine serum, and then incubated
with the primary antibody for at least one hour. Slides were washed three
times with PBS, and then incubated with conjugated secondary antibod-
ies for 1 h. Finally, the reaction was visualized with the Avidin-Biotin-
Complex (ABC) kit from DAKO (Vectastain Elite, Vector Laboratories, Inc,
Burlingame, CA) using diamino-benzidine as chromogenic substrate for
peroxidase. Slides were mounted and analyzed by light microscopy
(Leica DM RXA2), and microphotographs were taken at the indicated
magnification.
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In vivo epithelial BrdU labeling
Epithelial cell proliferation was measured by i.p. injection of BrdU (130
g/g of body weight, Roche) into pregnant female mice 1 h before
sacrifice. BrdU incorporation was detected by immunohistochemistry of
paraffin-embedded sections using a mouse anti-BrdU monoclonal anti-
body (biotest, Roche) followed by hematoxylin counterstaining. The
number of BrdU-positive cells and the number of total cells was deter-
mined per 200 m of interfollicular epithelium in each section. Experi-
ments were performed at least in five individuals of each genotype and
differences were assessed by using the t test, with statistical significance
when p < 0.05.
Analysis of apoptosis in tissue sections
To detect individual apoptotic cells in paraffin-embedded tissue sec-
tions, the In situ Cell Death Detection kit (Roche) was used, following
manufacturer´s recommendation. Paraffin sections immersed in 0.1 M
citrate buffer, pH 6 were microwave-irradiated for 5 min, and then rinsed
with PBS prior to the TUNEL reaction. Four 15.5 dpc embryos of each
genotype were examined.
Measurements of eyelid formation, leading edge formation and root
formation
We have quantitated the differences in eyelid formation of GR-/- vs wt
E15.5 littermates, following the methodology described by Mine et al.
These measurements were done in slides that were stained with K6, in
order to delimitate the migrating epitheliall cells as K6-positive cells. This
migration distance was considered as parameter a; the distance between
the axis delimitating the conjunctival sac and the first K6-stained cells was
denominated as b; the distance between the axis delimitating the conjunc-
tival sac and the center of the cornea was denominated as c. The
percentage of root formation was calculated as [b/c] x 100; percentage of
leading edge formation was calculated as [a/c] x 100, and the percentage
of eyelid formation was [(a+b)/c] x 100. Calculations were done in five
individuals of each genotype and differences considered to be statistically
significant when p<0.05.
MPK isolation, culture and wound scratch
MPK isolation was performed as previously described (Bayo et al.,
2008). Briefly, skin was peeled off, incubated in 0.25% trypsin to separate
the epidermis from the dermis and homogenized. MPKs were pooled
(using at least two mice per point) and 106 cells were plated into one 35
mm diameter collagen coated petri dish (BD Biosciences) and cultured at
37C in standard medium. After 24 h, the medium was replaced with
complete low calcium medium and cells were grown until confluency. The
composition of standard medium was: Essential modified Eagle´s me-
dium EMEM (BioWhitakker, Inc., Walkersville, MD), supplemented with
4% fetal calf serum (FCS, BioWhitakker, Inc.) plus 0.6 mM CaCl2 and
antibiotics. To prepare low-calcium medium, FCS was depleted of diva-
lent cations by treatment with Chelex deionizing resin (BioRad, Hempstead,
UK) and supplemented with CaCl2 to a final concentration of approxi-
mately 0.05 mM. EGF (Sigma, St. Louis, MO) (10 ng/ml) and antibiotics
were added to growth medium.
For wound scratch assays, MPKs were incubated in EMEM/1% FBS
O/N, and then treated with mitomycin (10g/ml) for 1h. Next, cells were
wounded with a yellow tip, treated as indicated and cell migration followed
up for 8-24h. Experiments were performed in triplicate and mean value 
SD estimated. Vehicle, Dexamethasone (Dex, Sigma, St. Louis, MO, 100
nM) or EGF (25 ng/ml) were added for the indicated times to confluent wt
MPKs.
For each wound scratch experiment, the surface area that remained
uncovered by the cells for each time-point and condition was quantitated
(Adobe Photoshop 8.1.0). These measurements were expressed as a
percentage of distance coverage by cells moving into the scratch wound
area 8 h and 24 h after wounding. Six images were analyzed per condition
and time-point; then, averages and standard deviations were calculated.
RNA preparation and quantitative RT-PCR
Total RNA was isolated from back skin of GR-/- and control littermates
(four animals of each genotype) by using Trizol reagent (Invitrogen,
Molecular Probes, Eugene, Oregon), following manufacturer´s recom-
mendations. Reverse transcription was performed by using 1 g of RNA
and oligo-dT (Fermentas Inc., Burlington, Canada) followed by qPCR
using specific oligonucleotides for egfr
Forward, 5´-CAAAGTGATGTCTGGAGCTAT-3‘;
Reverse, 5´CTTGCTGGGATTCCATCATAAG-3‘. Technical triplicates
were performed and mean value  SD estimated.
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